Horizon Pharma Offers to Acquire Hyperion Therapeutics for $1.1 Billion CHAD BRAY The Irish pharmaceutical company has offered to pay $46 a share in cash for Hyperion, representing a 7.6 percent premium to its closing price on Friday. March 31, 2015 at 12:00AM http://nyti.ms/1EUn5Wh The New York Times Business Day Mergers, Acquisitions and Divestitures, Drugs (Pharmaceuticals), Stocks and Bonds

By CHAD BRAY via NYT / Eethg. Corps. Inc. / Terrence Herschel G. Business Day http://nyti.ms/1EUn5Wh Horizon Pharma Offers to Acquire Hyperion Therapeutics for $1.1 Billion March 31, 2015 at 12:00AM The New York Times